Wednesday, July 8, 2026

pharma · Postoperative Pain · Pain · PCRX

Pacira Ireland

Pacira Ireland is a pharma organization headquartered in Ranelagh, IE. It trades on NYSE under ticker PCRX. Primary therapeutic focus areas include Postoperative Pain, Pain, Postoperative Pain Management, Osteoarthritis,

Ranelagh, IE HQ
2007 Founded
7 Employees
Public company Type
PCRX · NYSE Ticker
Company details
Status
Public
HQ
Ranelagh, IE
Founded
2007
Employees
7
Programs
100
Drugs
32
Patents
57
Clinical program

FX006 32 mg

Phase 3 · small molecule · Osteoarthritis, Knee

FX006 32 mg for Osteoarthritis, Knee is a Phase 3 program (small_molecule) at Pacira Ireland Limited with 1 ClinicalTrials.gov record(s).

← All Pacira Ireland Limited projects Phase 3 small molecule completed

Internal code FX006-2017-014

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Pacira Ireland Limited
Phase
Phase 3
Modality
small_molecule
Indication
Osteoarthritis, Knee
Status
completed
Trials
1

Clinical trials